GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Matricelf Ltd (OTCPK:MTRLF) » Definitions » Institutional Ownership

Matricelf (Matricelf) Institutional Ownership : 0.09% (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Matricelf Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Matricelf's institutional ownership is 0.09%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Matricelf's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Matricelf's Float Percentage Of Total Shares Outstanding is 0.00%.


Matricelf Institutional Ownership Historical Data

The historical data trend for Matricelf's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Matricelf Institutional Ownership Chart

Matricelf Historical Data

The historical data trend for Matricelf can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 0.06 0.06 0.06 0.05 0.08 0.09 0.09 0.09 0.09 0.09

Matricelf Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Matricelf (Matricelf) Business Description

Traded in Other Exchanges
Address
Golda Meir 3, Ness Ziona, ISR, 6701838
Matricelf Ltd is engaged in research and development in the field of medicine and tissue engineering. It is a pioneering biotechnology company developing a platform for autologous matrix and cells implants for a wide range of medical conditions.

Matricelf (Matricelf) Headlines